32. Consolidated companies as of 31 December 2015
Name of the subsidiary |
Country |
% voting right Galapagos NV (directly or indirectly through subsidiaries) |
Change in % voting right previous period (2015 vs 2014) |
||
|
|||||
Continuing operations |
|
|
|
||
BioFocus DPI AG |
Switzerland |
100% |
|
||
BioFocus DPI LLC |
United States |
100% |
|
||
BioFocus, Inc. |
United States |
100% |
|
||
Discovery Partners International GmbH |
Germany |
100% |
|
||
Galapagos BV |
The Netherlands |
100% |
|
||
Galapagos NV |
Belgium |
parent company |
|
||
Fidelta d.o.o. |
Croatia |
100% |
|
||
Galapagos SASU |
France |
100% |
|
||
Inpharmatica Ltd. |
United Kingdom |
100% |
|
||
Xenometrix, Inc. |
United States |
100% |
|
||
|
|
|
|
||
Discontinued operations * |
|
|
|
||
Argenta Discovery 2009 Ltd. |
United Kingdom |
0% |
0% |
||
BioFocus DPI (Holdings) Ltd. |
United Kingdom |
0% |
0% |
||
BioFocus DPI Ltd. |
United Kingdom |
0% |
0% |
||
Cangenix Ltd. |
United Kingdom |
0% |
0% |
||
There are no significant restrictions on the Group’s ability to access or use assets, and settle liabilities of one of the Group’s subsidiaries.